Consequences of reductions in hospital readmissions

Gregg C. Fonarow*, Clyde W. Yancy

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)1933-1934
Number of pages2
JournalJAMA - Journal of the American Medical Association
Volume318
Issue number19
DOIs
StatePublished - Nov 21 2017

Funding

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Fonarow reported serving as a consultant to Amgen, Janssen Pharmaceutical, Medtronic, Novartis, and St Jude Medical; receiving grants to his institution from the National Institutes of Health; and serving on a speakers bureau for Novartis. No other disclosures were reported.

ASJC Scopus subject areas

  • General Medicine

Cite this